Super Bowl champions Bruce Arians and Rob Gronkowski star in a cheeky Super Bowl ad from Novartis designed to encourage men to get screened for prostate cancer with an easy blood test. Arians and ...

The IAEA is launching a year-long coordinated research project to develop computed tomography-based guidelines on prostate cancer contouring — a critical step in the cancer treatment process that ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Adverts for at-home prostate cancer tests that claim to offer a diagnosis, including one that suggests patients can “skip the doctors” have been banned by watchdogs. The Advertising Standards ...

John Eimen, a former child star known for his guest spot in "Leave it to Beaver," died Friday, Nov. 21, a representative confirmed. He was 76. Eimen died at his home in Mukilteo, Washington, from ...

Samsung Electro-Mechanics is reportedly set to supply advanced semiconductor glass substrates to Broadcom. The move comes as Broadcom, a key chip supplier for tech giants like Google and Meta, secured ...

Note: While research on alcohol is evolving, the Centers for Disease Control and Prevention says drinking less or not at all is better for your health. Alcohol is part of many people’s social lives, ...

Stage 2 prostate adenocarcinoma is localized, with a nearly 100%, five-year relative survival rate. Diagnosis uses the TNM system, PSA levels and Gleason score to determine cancer stage and risk.

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

A major health update has been shared by the family of former president Joe Biden following the announcement of his aggressive prostate cancer diagnosis. Ashley Biden, the former president’s daughter, ...

A newly uncovered mechanism thought to be a weakness of prostate cancer cells could inspire a new and improved targeted treatment for the disease. International research led by Flinders University in ...